Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffb47471ca2f425ad41df9479675be1f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-33 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2020-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5cabd9e5ff753941f9933b9939c8acb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f024ba720fd6ad5f0462824cd6e1c375 |
publicationDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021062188-A1 |
titleOfInvention |
Compositions and uses for treatment thereof |
abstract |
The invention is directed generally to oligonucleotide compositions for the treatment of DNA repeat expansion diseases. The invention also relates to oligonucleotides directed to subunits of the DNA mismatch repair system. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023114989-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11408000-B2 |
priorityDate |
2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |